X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1198) 1198
animals (1058) 1058
transplantation (984) 984
male (828) 828
surgery (695) 695
female (655) 655
adult (391) 391
middle aged (353) 353
rats (348) 348
heart transplantation - adverse effects (320) 320
mice (311) 311
immunology (257) 257
treatment outcome (247) 247
heart (243) 243
heart transplantation (228) 228
stem cells (225) 225
transplantation, homologous (217) 217
transplantation, heterotopic (215) 215
analysis (213) 213
time factors (210) 210
disease models, animal (194) 194
cardiac & cardiovascular systems (190) 190
graft rejection (183) 183
graft rejection - prevention & control (182) 182
transplants & implants (175) 175
aged (172) 172
orthopedics (172) 172
health aspects (163) 163
medicine & public health (163) 163
graft rejection - immunology (161) 161
research (159) 159
graft survival (155) 155
rejection (152) 152
transplantation of organs, tissues, etc (152) 152
adolescent (151) 151
mice, inbred c57bl (151) 151
allografts (146) 146
rats, inbred lew (145) 145
medicine, research & experimental (137) 137
respiratory system (135) 135
retrospective studies (134) 134
follow-up studies (132) 132
immunosuppressive agents - therapeutic use (132) 132
immunosuppression (131) 131
risk factors (127) 127
cancer (122) 122
care and treatment (121) 121
cryopreservation (119) 119
tissue engineering (118) 118
transplantation, autologous (117) 117
swine (114) 114
mice, inbred balb c (112) 112
in-vitro (111) 111
survival (111) 111
expression (109) 109
cell biology (106) 106
medicine (104) 104
bone marrow (103) 103
abridged index medicus (98) 98
liver (97) 97
child (96) 96
pregnancy (96) 96
graft rejection - pathology (94) 94
young adult (93) 93
heart transplantation - immunology (92) 92
review (90) 90
transplantation, heterotopic - adverse effects (90) 90
regeneration (88) 88
graft survival - drug effects (87) 87
oncology (87) 87
fertility preservation (85) 85
internal medicine (85) 85
immunohistochemistry (84) 84
medical research (83) 83
immunotherapy (82) 82
inflammation (82) 82
kidney transplantation (82) 82
cells (81) 81
hematology (81) 81
in-vivo (81) 81
obstetrics & gynecology (81) 81
usage (81) 81
t cells (78) 78
therapy (78) 78
cells, cultured (77) 77
fertility (77) 77
stem cell transplantation (77) 77
cell & tissue engineering (76) 76
graft rejection - etiology (76) 76
recipients (76) 76
heart transplantation - methods (75) 75
bone transplantation - methods (74) 74
lung transplantation (73) 73
models, animal (73) 73
bone-marrow (72) 72
liver transplantation (72) 72
reoperation (72) 72
stromal cells (72) 72
graft survival - immunology (71) 71
rodents (71) 71
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2041) 2041
French (17) 17
Chinese (12) 12
German (9) 9
Spanish (9) 9
Japanese (8) 8
Russian (3) 3
Croatian (2) 2
Czech (2) 2
Italian (2) 2
Norwegian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Medicine (United States), ISSN 0025-7974, 07/2017, Volume 96, Issue 27, p. e7413
...) is yet to be elucidated. The heterotopic ossification (HO) after rhBMP-2 usage in some orthopedic surgeries has been reported previously... 
heterotopic ossification | bone regeneration | recombinant human bone morphogenetic protein-2 | bone grafting | osteonecrosis of femoral head | BONE MORPHOGENETIC PROTEIN-2 | ARTHROPLASTY | INDUCTION | HIP | FAMILY | MEDICINE, GENERAL & INTERNAL | GROWTH-FACTOR-BETA | INTERBODY FUSION | NECROSIS | FRACTURES | DIFFERENTIATION | Recombinant Proteins - therapeutic use | Femur Head Necrosis - diagnostic imaging | Follow-Up Studies | Intraoperative Care - adverse effects | Humans | Middle Aged | Male | Recombinant Proteins - adverse effects | Ossification, Heterotopic - chemically induced | Femur Head - drug effects | Femur Head Necrosis - drug therapy | Bone Morphogenetic Protein 2 - adverse effects | Young Adult | Transforming Growth Factor beta - therapeutic use | Bone Morphogenetic Protein 2 - therapeutic use | Transforming Growth Factor beta - adverse effects | Adult | Female | Retrospective Studies | Femur Head Necrosis - complications | Femur Head - diagnostic imaging | Postoperative Complications - chemically induced | Femur Head Necrosis - surgery | Risk Factors | Ossification, Heterotopic - diagnostic imaging | Femur Head - surgery | Growth Substances - adverse effects | Growth Substances - therapeutic use | Bone Transplantation | Survival Analysis | Postoperative Complications - diagnostic imaging | CT imaging | Usage | Care and treatment | Bone morphogenetic proteins | Bones | Bone-grafting | Necrosis
Journal Article
Review of Diabetic Studies, ISSN 1613-6071, 2014, Volume 11, Issue 1, pp. 84 - 101
Journal Article
Journal Article
Journal Article
Spine, ISSN 0362-2436, 12/2007, Volume 32, Issue 25, pp. 2885 - 2890
.... The use of rhBMP2 for interbody fusion is associated with high fusion rates. However, for posterior approaches, concerns regarding heterotopic bone formation within the epidural space have been raised. Methods... 
Minimally invasive surgery | Bone morphogenetic protein | Posterior lumbar interbody fusion | Transforaminal interbody fusion | NOGGIN | trans-foraminal | interbody fusion | minimally invasive surgery | SAFETY | CAGES | posterior lumbar interbody fusion | ORTHOPEDICS | bone morphogenetic protein | CLINICAL NEUROLOGY | MORPHOGENETIC PROTEIN-2 | Prospective Studies | Follow-Up Studies | Spinal Cord Diseases - physiopathology | Humans | Middle Aged | Bone Transplantation - adverse effects | Male | Tomography, X-Ray Computed | Recombinant Proteins - adverse effects | Spinal Fusion - adverse effects | Ossification, Heterotopic - chemically induced | Incidence | Lumbar Vertebrae - surgery | Back Pain - surgery | Time Factors | Transforming Growth Factor beta - adverse effects | Adult | Female | Spinal Cord Diseases - diagnostic imaging | Minimally Invasive Surgical Procedures | Back Pain - etiology | Disability Evaluation | Severity of Illness Index | Spinal Fusion - methods | Spinal Diseases - surgery | Spinal Diseases - complications | Bone Morphogenetic Protein 2 | Ossification, Heterotopic - diagnostic imaging | Treatment Outcome | Epidural Space - diagnostic imaging | Bone Morphogenetic Proteins - adverse effects | Spinal Cord Diseases - chemically induced | Ossification, Heterotopic - physiopathology | Epidural Space - drug effects | Aged | Pain Measurement | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9687, pp. 387 - 392
Journal Article
Diabetes (New York, N.Y.), ISSN 1939-327X, 2016, Volume 65, Issue 5, pp. 1350 - 1361
Transplantation of pancreatic islets is a therapeutic option to preserve or restore -cell function. Our study was aimed at developing a clinically applicable... 
LONG-TERM | DIABETES-MELLITUS | CELLS | MEDIATED INFLAMMATORY REACTION | OMENTAL POUCH SITE | ENDOCRINOLOGY & METABOLISM | GRAFT-SURVIVAL | COLD PRESERVATION | HEPATIC STEATOSIS | TISSUE FACTOR | BLOOD | Tissue Scaffolds - adverse effects | Diabetes Mellitus, Experimental - surgery | Pancreas, Artificial - adverse effects | Biocompatible Materials - chemistry | Rats, Inbred Lew | Macaca fascicularis | Male | Omentum | Recombinant Proteins - adverse effects | Feasibility Studies | Tissue Scaffolds - chemistry | Diabetes Mellitus, Experimental - blood | Islets of Langerhans Transplantation - immunology | Plasma - metabolism | Immunosuppression - adverse effects | Islets of Langerhans Transplantation - adverse effects | Islets of Langerhans - cytology | Islets of Langerhans Transplantation - pathology | Surface Properties | Female | Islets of Langerhans - ultrastructure | Rats, Inbred WF | Tissue Engineering | Recombinant Proteins - metabolism | Hyperglycemia - prevention & control | Microscopy, Electron, Scanning | Recombinant Proteins - chemistry | Biomarkers - blood | Islets of Langerhans Transplantation - methods | Diabetes Mellitus, Experimental - immunology | Animals | Thrombin - chemistry | Transplantation, Isogeneic - adverse effects | Plasma - chemistry | Transplantation, Heterologous - adverse effects | Diabetes Mellitus, Experimental - pathology | Transplantation, Heterotopic - adverse effects | Thrombin - adverse effects | Thrombin - metabolism | Biocompatible Materials - adverse effects | Islet cell transplantation | Usage | Clinical trials | Dosage and administration | Inflammation | Research | Glucose tolerance tests | Insulin | Risk factors | Immunology and Transplantation
Journal Article